Last checked at 12 Mar 2021 13:48
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 11 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,805,264 | 1.40% | 181,707 | 0.14% | ||
(2) | Derivatives (other than options): | ||||
103,127 | 0.08% | 7,066 | 0.01% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
1,914,491 | 1.48% | 194,873 | 0.15% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 222.2700 USD |
Purchase | 1 | 221.9600 USD |
Purchase | 1 | 222.7700 USD |
Purchase | 3 | 222.4833 USD |
Purchase | 3 | 222.2400 USD |
Purchase | 6 | 222.3708 USD |
Purchase | 12 | 224.4600 USD |
Purchase | 24 | 222.2975 USD |
Purchase | 33 | 222.2900 USD |
Purchase | 50 | 221.9900 USD |
Purchase | 63 | 221.9100 USD |
Purchase | 67 | 222.7740 USD |
Purchase | 99 | 222.4800 USD |
Purchase | 100 | 222.5096 USD |
Purchase | 137 | 223.3600 USD |
Purchase | 200 | 222.3375 USD |
Purchase | 226 | 222.4581 USD |
Purchase | 240 | 222.4700 USD |
Purchase | 289 | 222.0416 USD |
Purchase | 400 | 222.1075 USD |
Purchase | 418 | 222.5865 USD |
Purchase | 425 | 222.2670 USD |
Purchase | 754 | 224.2300 USD |
Purchase | 897 | 222.2100 USD |
Purchase | 1,362 | 222.4744 USD |
Purchase | 1,384 | 222.2945 USD |
Purchase | 1,389 | 222.3323 USD |
Purchase | 1,510 | 222.2828 USD |
Purchase | 1,517 | 222.4934 USD |
Purchase | 1,652 | 222.2055 USD |
Purchase | 2,433 | 222.1160 USD |
Purchase | 2,702 | 222.7751 USD |
Purchase | 3,703 | 222.2578 USD |
Purchase | 5,166 | 222.3426 USD |
Purchase | 5,674 | 222.5275 USD |
Purchase | 5,919 | 222.3378 USD |
Purchase | 8,454 | 222.4447 USD |
Purchase | 10,404 | 222.4470 USD |
Purchase | 38,875 | 222.4630 USD |
Sale | 11 | 224.0000 USD |
Sale | 12 | 224.4600 USD |
Sale | 14 | 222.1600 USD |
Sale | 37 | 222.9300 USD |
Sale | 54 | 221.9900 USD |
Sale | 100 | 222.0475 USD |
Sale | 100 | 222.0550 USD |
Sale | 103 | 222.9911 USD |
Sale | 200 | 223.2100 USD |
Sale | 289 | 222.2100 USD |
Sale | 309 | 222.2129 USD |
Sale | 754 | 224.2300 USD |
Sale | 1,667 | 222.2069 USD |
Sale | 3,758 | 222.3591 USD |
Sale | 3,917 | 222.6497 USD |
Sale | 4,284 | 222.3248 USD |
Sale | 5,498 | 222.4930 USD |
Sale | 6,058 | 222.5045 USD |
Sale | 6,119 | 222.3378 USD |
Sale | 8,590 | 222.3216 USD |
Sale | 10,000 | 222.4161 USD |
Sale | 44,111 | 222.4470 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 12 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210312005284/en/
Copyright Business Wire 2021